News
VITUS presents impressive results on treatment of high-grade prostate cancer at World Congress
Patients with so-called high-grade prostate cancer often struggle with severe side effects after a standard treatment. Our data shows that IRE as a treatment method…
Read MoreRadioligand therapy (RLT) using Lu-177 labelled PSMA for metastatic prostate cancer
Radioligand therapy (RLT) using Lu-177 labelled PSMA is a novel and promising therapeutic approach to treat metastatic prostate cancer. We explain how the therapy works. Lu-177…
Read MoreHow Electricity Can Effectively Kill Cancer
Prostate cancer is the most common cancer in men, affecting 25% of all men. The standard treatments are time-consuming and associated with significant side effects.…
Read MoreHow Vitus Prostate Revolutionizes Virtual Real-time Precision Guidance for Prostate Cancer Treatment
The Vitus Prostate Center in Offenbach, Germany accompanies and advises the medical team of the Vitus Prostate Center San Diego in treatments of prostate cancer…
Read MoreProstate Cancer is a Women’s Problem?
Prostate Cancer is a Women’s Problem? The American Cancer Society states that after skin cancer, prostate cancer is the second most common cancer in men.…
Read MoreDr. Ross Schwartzberg – Prostate Cancer San Diego – Talk Radio
In a relatively light-hearted interview for such a serious topic Dr. Schwartzberg talks about Prostate Cancer and outlines in clear terms some of the essential…
Read MoreFive Prostate Cancer Treament Options
Doctors and healthcare professionals (including oncology specialists, scientists, physician assistants, and others) often work together to establish a targeted treatment plan for prostate cancer taking…
Read More5 Things to know about PSA numbers
PSA or prostate specific antigen is a molecule secreted by both normal and cancerous cells of the prostate gland. PSA is commonly linked to prostate…
Read MoreMRI and Nanoknife/IRE treatment for Prostate Cancer in San Diego
“Living better in San Diego” interviewed Dr. Ross Schwartzberg on the topic of Prostate Cancer. You can listen the to the interview by clicking on…
Read More